Magnera (MAGN) Q3 FY26 earnings call: guidance and Q&A

What were the order patterns and cadence during Q3, and what are the expectations for July into the final fiscal quarter, considering any abnormalities?

Order patterns were very consistent with Q3, showing steady orders. No significant abnormalities or weather disruptions were observed. Inventory levels are in good position, and the company expects similar demand in Q4.

“Very consistent with what we experienced going into Q3, is what I would say, which is, again, order steady. We've been working closely with customers, and particularly those in certain geographies that had challenges receiving product due to the nature of challenges related to the war, particularly in the Middle East. But in terms of what we see from a demand outlook for the quarter, we see it to be very, very consistent. Our inventory levels are in a very good position, especially from a production standpoint. So we expect to see kind of more of the same this quarter that we saw in Q3.”

asked by Gabe Hajde · answered by Curtis Begle

Can you clarify the $405 million pro forma adjusted EBITDA target versus the initial $445 million, and the timeframe to achieve it, considering price/cost recovery and residual Project CORE/synergies?

The teams effectively managed pricing, achieving a net neutral impact in the Americas. A couple million dollars in Rest of World pricing lag will flow into Q4. The company anticipates $20 million from run-rate synergies and Project CORE to flow into 2027.

“What I would say is the teams did an excellent job in terms of going out with pricing and mirroring our flow through. Our flow through is pretty quick. Particularly in Americas, I would say that that was a net neutral for us. Now there is a couple million, as we highlighted in the commentary, in Rest of World that will flow into the fourth quarter in terms of the lag catch-up was part of your question. And then as we're looking, you know, we're not going to give 2027 guidance, but what I would say is I think we've told folks we're anticipating kind of $20 million floating over from those run rate synergies and CORE into 2027, and that remains our, we still believe that that's the case.”

asked by Gabe Hajde · answered by James Till

How does the price experience compare between Americas and Rest of World, and do you expect to fully catch up on pricing in ROW in Q4?

In the Americas, pricing actions resulted in a net neutral impact against costs. In Rest of World, there was a couple million dollar lag in pricing adjustments that is expected to flow through and catch up in the fourth quarter.

“Yes, so what I would say is it was a very collaborative exercise with sort of all customers globally in Asia and in the Americas. We were able to push those through. So it was sort of net neutral in terms of cost versus price, which was what our intent was and was our goal in the Rest of World in Europe. As you had highlighted, there is a couple million dollars that will flow into the fourth quarter as there was a bit of a lag in terms of getting those prices adjusted to reflect those increased costs.”

asked by Kevin McCarthy · answered by James Till

With one quarter left, what are the updated thoughts on achieving the reaffirmed free cash flow target range, considering working capital and other factors?

The company plans to offset the lower end of EBITDA guidance with reduced CapEx, now expected around $60 million for the full year. Working capital was a use this quarter but better than anticipated due to inventory management. There's still work to do on working capital in Q4, but management is confident in their initiatives.

“So we obviously moved to the lower end of the range on EBITDA. The easiest offset to that will be CapEx. So we originally guided roughly $80 million. We're rolling in around $15 million a quarter, so our natural run will be around $60 million. There was a working capital use this quarter as anticipated because of the inflation. The teams did a nice job of offsetting a good portion of that. It wasn't quite as much as we anticipated because of the efforts the teams did on inventories. But what I would say is there's still work to go there in the fourth quarter. And we knew we moved on very quickly on the impacts to EBITDA, and we knew that the working capital pieces, it was going to take us the entire back half to sort of offset those increases. And so I would say it's still work to go on the working capital, but we feel comfortable with initiatives that we have in place that we'll be able to get that back in order here in the fourth quarter.”

asked by Kevin McCarthy · answered by James Till

Are the shortened lag times for raw material pass-throughs a permanent change, or will they revert to longer lags in a more normalized environment?

In unprecedented times of rapid inflation, short-term monthly pass-throughs were critical. While some cases might remain consistent, in a more normalized environment, the company expects to revert to quarterly or bimonthly index moves. However, the overall intent is to shorten lags even further in new contract negotiations.

“And in cases like what we experienced coming into Q3 with the rapid inflation that we were experiencing, going to customers and working with them on short-term moves to the monthly pass-through was really critical in order for us to ensure that we were neutralizing negative impact. And so, you know, there will be some cases with customers that we would keep that in a consistent basis. But, you know, we would expect in the coming, you know, coming months, quarters, years that in a more normalized environment you would revert back to quarterly index moves or bimonthly. But I would say at the very least we've shortened overall those ranges, but we're very efficient in our pass-throughs in general.”

asked by Edward Brucker · answered by Curtis Begle

Should we expect the ~$60 million CapEx run rate to continue, or will there be deferred CapEx requiring catch-up in future years?

The company is not deferring any CapEx this year, focusing on ROI, maintenance, and safety. Larger growth investments are being managed efficiently. Future CapEx will adjust appropriately for major growth programs, but the company is comfortable with its current capital spend.

“I wouldn't say we're deferring anything this year. For us, it's a matter of making sure that we have the right amount of ROI in terms of the investments that we're making. We've obviously been heavily focused on the integration and ensuring the right investments from a maintenance standpoint, safety CapEx inside of the sites. In terms of the larger growth investments, we've been very efficient in identifying opportunities to improve existing platforms and lines. But as we go into future years, we would adjust that CapEx appropriately as it relates to any major growth programs or growth initiatives inside of the business. But we're very comfortable with where we sit today in terms of our capital dollar spend.”

asked by Edward Brucker · answered by Curtis Begle

Can you explain the Americas revenue bridge, specifically the negative $13 million price, given raw material pass-throughs, and how negative mix from Project CORE annualizes?

In Q1 and Q2, the company saw a negative $40 million impact from higher-priced, lower-profitability items that were walked away from as part of Project CORE. This impact continued in Q3 but was offset by inflationary items. This effect is expected to continue through the remainder of the year and annualize in Q1 2027.

“So if you remember in Q1 and Q2, we were running around $40 million negative in that line for exactly what you said. So it was higher priced, I guess, higher sales dollars, price per unit, but lower profitability. Items that we walked away from is Project CORE. So you saw that hitting us in Q1, Q2, hit us again in Q3, but it was offset with inflationary items. So we'll continue to lap that through the remainder of the year, and then it should sort of lap in Q1 of 2027.”

asked by Gabe Hajde · answered by James Till

Does the company track a vitality index or new product index, and what is the rough investment in R&D?

The company actively tracks a vitality index, with new innovation impact now close to north of 25% (historically 15-20%). They heavily invest in new product development and focus on shifting from commodity products to higher-margin, value-added offerings. More detailed R&D expense information can be provided on a future call.

“Yes, I don't have the total in terms of expenses as it relates to R&D. Obviously, we do continue to heavily invest in new product development, new features and benefits within certain product lines. We're excited about the Universa launch. And, you know, that'll be part of our forward run rate whenever we provide our '27 guide in Q4 and beyond. But in terms of the vitality index, we track that every quarter. And so, you know, historically, it's been about the 15% to 20% range. In terms of new innovation and the impact to the portfolio, that's, you know, close to north of 25%, and many of those products in some cases might be for a similar application than what we're doing today, but it provides more value to our customers, which in turn improves our overall mix, which is what we've been focused on as we looked at our portfolio and continue to evaluate the portfolio of where we have the long-term right to win, where we have true differentiation, how we can backstop that with our patents, our IP, and the customer collaboration.”

asked by Gabe Hajde · answered by Curtis Begle

Is exiting the Transition Services Agreements (TSAs) a financially meaningful event, or will it be a smooth transition from a modeling perspective?

Exiting the TSAs will be a cash benefit, as the one-time integration costs associated with them will begin to ramp down as the integration finishes over the next few quarters.

“Yes, what you'll see is we're still spending money on the TSA. So you have one-time cost associated with Kevin. So when we talk about the integration costs, those will begin to ramp down as we exit the TSA and finish the integration through kind of the next few quarters. So financial, I would say from a cash standpoint, it will be a cash benefit.”

asked by Kevin McCarthy · answered by James Till

What is the current status of Project CORE, and is it largely complete in terms of asset rationalization actions?

The company is ahead of schedule on the initial wave of Project CORE, which involved challenging decisions like shutting down facilities and idling assets. While still integrating some work, they continue to evaluate opportunities for productivity improvements and portfolio enhancement. Wave 1 was the most straightforward, and additional pipeline initiatives will be evaluated for 2027 and beyond.

“I would say that, again, as Jim talked about in our commentary, we're very proud of what the team was able to accomplish when we, I think it was this call last year, when we announced Project CORE and what we were doing from, you know, the challenging decisions of shutting down facilities, idling certain assets, and moving some of our products around as we cross qualified in other sites. Still integrating some of that work, but in general, real ahead of schedule in terms of what we kind of expected. And we continue to evaluate, Kevin, opportunities for productivity improvements, and as I mentioned before, really focused on the portfolio and how we can continue to enhance that from a vitality index standpoint, but higher margin products on the right platforms, in the right regions, with the right customers.”

asked by Kevin McCarthy · answered by Curtis Begle